rs267607269
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_000517.6(HBA2):c.344C>G(p.Pro115Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P115L) has been classified as Likely benign.
Frequency
Consequence
NM_000517.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 25
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 25
ClinVar
Submissions by phenotype
HBA2-related disorder Uncertain:1
The HBA2 c.344C>G variant is predicted to result in the amino acid substitution p.Pro115Arg. This variant is also known as Hb Chiapas or p.Pro114Arg using legacy nomenclature. Individuals carrying this variant were described as clinically normal (Lisker et al. 1966. PubMed ID: 5945763; Jones et al. 1968. PubMed ID: 5650416; Ibarra et al. 1981. PubMed ID: 7319830). This variant has not been reported in a large population database, indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
not provided Uncertain:1
The Hb Chiapas (HBA2: c.344C>G; p.Pro115Arg, also known as Pro114Arg when numbered from the mature protein, rs267607269, HbVar ID:176) is reported in the literature in an heterozygous individual during surveys with no known associated clinical symptoms (Jones 1968, Ibarra 1981, HbVar and references therein). This variant is not reported in ClinVar and is absent from the Genome Aggregation Database, indicating it is not a common polymorphism. Although the resulting Hb product was readily identifiable by electrophoresis and was tested as normal stability (Ibarra 1981), there is no other functional and structural outcome known. The phenotype of this variant in the presence of other alpha globin variants is unknown either. The proline at codon 115 is moderately conserved, but computational are uncertain whether this variant is neutral or deleterious (REVEL: 0.468). Due to limited information, the clinical significance of the Hb Chiapas variant is uncertain at this time. References: Jones, R. T., et al. Chemical characterization of hemoglobinMexico and hemoglobinChiapas. Biochimica et Biophysica Acta (BBA). Protein Structure 1968; 154(3): 488-495. Ibarra B et al. Hb Chiapas alpha 2 114 Pro replaced by Arg beta 2: identification by high pressure liquid chromatography. Hemoglobin. 1981;5(6):605-8. PMID: 7319830. Link to HbVar database: https://globin.bx.psu.edu/hbvar/menu.html -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at